Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severely impacts quality of life, mental health, and work productivity.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Activated platelet-rich plasma is a safe and effective treatment for hair loss.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Finasteride 1 mg/day for five years effectively improves hair growth and slows hair loss in men with male pattern baldness, and is safe for long-term use.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

AGA affects many, progresses differently, and early treatment is crucial.

Serial trichoscopy is more reliable than the modified hair pull test for tracking alopecia areata.

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

Finasteride is effective and safe for long-term treatment of hair loss in Japanese men.

COVID-19 can increase the risk of hair loss, especially in people over 40.